| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
LY2090314
|
603288-22-8 |
LY 29314
|
CS-843;LY2090314;LY 2090314;LY-2090314;LY 2090314;LY-2090314;LY2090314 100MG
|
C28H25FN6O3 |
512.5349032 | |
|
XL-888
|
1149705-71-4 |
XL888
|
XL888;XL-888;XL 888;CS-2629;CS-831
|
C29H37N5O3 |
503.63578 | |
|
TIC10
|
41276-02-2 |
TIC-1
|
7-benzyl-10-(2-Methylbenzyl)-2,6,7,8,9,10-hexahydroiMidazo[1,2-a]pyrido[4,3-d]pyriMidin-5(3H)-one;TIC 10;TIC10;TIC-10;2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one;NSC 350625;ONC201，NSC 350625;Imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one, 2,6,7,8,9,10-hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)-
|
C24H26N4O |
386.48944 | |
|
5-Iodotubercidin
|
24386-93-4 |
5-碘代杀结核菌素
|
5-碘代杀结核菌素;7-去氮-7-碘代腺苷;CS-824;5-碘-杀结核菌素;异结核菌素
|
C11H13IN4O4 |
392.15 | 200-001-2 |
|
NSC697923
|
343351-67-7 |
NSC697923
|
2-[(4-甲基苯基)磺酰基]-5-硝基呋喃
|
C11H9NO5S |
267.25786 | |
|
1-Azakenpaullone
|
676596-65-9 |
1-氮杂坎帕罗酮
|
1-氮杂坎帕罗酮
|
C15H10BrN3O |
328.1634 | 200-258-5 |
|
JZL184
|
1101854-58-3 |
JZL-184
|
JZL-184;JZL 184
|
C27H24N2O9 |
520.48746 | |
|
AMD 3465 Hexahydrobromide
|
185991-07-5 |
AMD 3465
|
AMD3465;AMD-3465;AMD 3465;AMD 3465;CS-810;N-[[4-(1,4,8,11-四氮杂环十四烷-1-甲基)苯基]甲基]-2-吡啶甲胺氢溴酸盐;AMD3465,98%;GENZ-644494
|
C24H44Br6N6 |
410.59872 | |
|
AZD1080
|
612487-72-6 |
AZD18
|
5-[[(4-碘苯基)氨基]亚甲基]-2,2-二甲基-1,3-二恶烷-4,6-二酮;2-羟基-3-[5-[(吗啉-4-基)甲基]吡啶-2-基]-1H-吲哚-5-甲腈;CS-809;AZD 1080;AZD-1080;2-羟基-3-[5-(吗啉-4-甲基)吡啶-2-基]-1H-吲哚-5-甲腈
|
C19H18N4O2 |
334.37182 | |
|
Oclacitinib
|
1208319-26-9 |
奥拉替尼
|
PF03394197;N-二甲基-1-((1R,4R)-4-甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)环己基)甲磺酰胺;奥拉替尼;PF03394197>98%;PF03394197;PF 03394197;奥克西替尼
|
C15H23N5O2S |
337.44042 | |
|
Abemaciclib mesylate
|
1231930-82-7 |
LY2835219
|
LY 2835219N-[5-[(4-乙基-1-哌嗪基)甲基]-2-吡啶基]-5-氟-4-[4-氟-2-甲基-1-异丙基-1H-苯并咪唑-6-基]-2-嘧啶胺甲烷磺酸盐;LY2835219甲磺酸盐;N-(5-((4-甲基哌嗪-1-基甲基)吡啶-2-基)-5氟-4-(4-氟-1-异丙基-2-甲基-1H-苯并[D]咪唑-6-基)嘧啶-2-胺甲磺酸盐;N-[5-[(4-乙基-1-哌嗪基)甲基]-2-吡啶基]-5-氟-4-[4-氟-2-甲基-1-异丙基-1H-苯并咪唑-6-基]-2-嘧啶胺甲烷磺酸盐
|
C27H32N8F2.CH4O3S |
602.69904 | |
|
GSK2656157
|
1337532-29-2 |
GSK2656157
|
5-[4-氟-1-[(6-甲基-2-吡啶基)乙酰基]-2,3-二氢-1H-吲哚-5-基]-7-甲基-7H-吡咯并[2,3-D]嘧啶-4-胺;CS-804
|
C23H21FN6O |
416.450843 | |
|
Birinapant (TL32711)
|
1260251-31-7 |
BIRINAPANT
|
(2S,2'S)-N,N'-[(6,6'-DIFLUORO[2,2'-BI-1H-INDOLE]-3,3'-DIYL)BIS[METHYLENE[(2R,4S)-4-HYDROXY-2,1-PYRRO;TL-32711 ≥98%;TL-32711;TL32711;TL 32711. BIRINAPANT;CS-801;比瑞那帕
|
C42H56F2N8O6 |
806.940846 | |
|
XL 019
|
945755-56-6 |
XL19
|
XL019;XL-019;XL 019.;XL019>95%;(S)-N-(4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)PHENYL)PYRROLIDINE-2-CARBOXAMIDE;(2S)-N-[4-[2-[[4-(4-吗啉基)苯基]氨基]-4-嘧啶基]苯基]-2-吡咯烷甲酰胺
|
C25H28N6O2 |
444.52882 | |
|
AZD3514
|
1240299-33-5 |
AZD3514
|
AZD 3514;AZD-3514;AZD3514;AZD-3514;AZD 3514;CS-795
|
C25H32F3N7O2 |
519.56249 | |
|
VCH-916
|
1200133-34-1 |
VCH-916
|
5-(1-环己烯-1-基)-3-[(反式-4-甲氧基环己基)[(反式-4-甲基环己基)羰基]氨基]噻吩-2-羧酸钾盐;CS-790;VCH 916;VCH916
|
C26H36KNO4S |
497.73164 | |
|
(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide
|
1038915-64-8 |
MK-4827
|
尼拉帕利盐酸盐;苯甲酸尼拉帕利;尼拉帕尼盐酸盐;盐酸尼拉帕尼;CS-787;甲苯磺酸尼拉帕利
|
C19H20N4O |
320.3883 | |
|
HSP-990
|
934343-74-5 |
HSP-99
|
(R)-2-氨基-7-[4-氟-2-(6-甲氧基吡啶-2-基)苯基]-4-甲基-7,8-二氢-6H-吡啶并[4,3-D]嘧啶-5-酮
|
C20H18FN5O2 |
379.3876232 | |
|
Besifloxacin Hydrochloride
|
405165-61-9 |
盐酸贝西沙星
|
盐酸贝西沙星(BESIFLOXACIN HYDROCHLORIDE);盐酸贝西沙星中间体;CS-781;(R)-7-(3-氨基氮杂环庚烷-1-基)-8-氯-1-环丙基-6-氟-4-氧代-1,4-二氢喹啉-3-甲酸 盐酸盐;BESIFL氧杂CIN 盐酸盐;贝西沙星盐酸盐;盐酸贝西沙星
|
C19H21ClFN3O3.HCl |
430.305 | 696-612-6 |
|
lixivaptan
|
168079-32-1 |
利伐普坦
|
利伐普坦;利昔伐坦;VPA985;LIXIVAPTAN (VPA 985);CS-781;利希普坦
|
C27H21ClFN3O2 |
473.933 | 605-500-8 |
药智官方微信
药智官方微博
